Roche Shares Update on the Investigation of Satralizumab for Bone Health and the SHIELD DMD Study

February 20, 2026

On February 20, 2026, Roche shared an important update in a community letter regarding their work in bone health in Duchenne and the SHIELD DMD study.

Read more by visiting their community letter here.

Jett Foundation’s Silver Soirée
Thursday, June 11, 2026 | 5:30PM
Granite Links | Quincy, MA